INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "INTEIN BASED SPLIT GLUTAMINE SYNTHETASE ENGINEERING"

GENEVA, Dec. 10 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, California 91320-1799) filed a patent application (PCT/US2025/031460) for "INTEIN BASED SPLIT GLUTAMINE SYNTHETASE ENGINEERING" on May 29, 2025. With publication no. WO/2025/250814, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHAO, Liangjun (c/o Amgen Inc., One Amgen Center DriveLaw Dept-Patent Operations, Mail Stop 28-5-AThousand Oaks, California 91320-1799), GONG, Danyang (c/o Amgen Inc., One Amgen Center DriveLaw Dept-Patent Operations, Mail Stop 2...